Insider trade

CFO sold ~$139K of HIMS shares in the open market

Traded Feb 3, 2026 · Filed Feb 4, 2026

Why it stands out

The money chief of Hims & Hers Health sold $139K of Hims & Hers Health shares. It happened by itself, for taxes or pay.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

CFO$100K–$500KPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$139,108

Shares × reported transaction price

Timing vs results

92 days after results of Nov 3, 2025, 20 days before results of Feb 23, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Filing box checked: sold under a Rule 10b5-1 plan

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	−32.7%	+0.5%	−33.3%
30 days	−5.6%	+0.1%	−5.7%
90 days	+14.5%	+8.3%	+6.2%
180 days	+37.0%	+13.8%	+23.1%

Past results only. Not a forecast.

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $26.35-$26.56. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Scheduled in advance7mo ago

7mo ago

Compensation award — excluded from discretionary-purchase analysis.

7mo ago

Compensation award — excluded from discretionary-purchase analysis.